Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Phentolamine Mesylate

U.S. FDA Requirements: Phentolamine Mesylate

Pharmaceutical / Drug Definition : Competitively blocks postsynaptic (alpha1) and presynaptic (alpha2) adrenergic receptors. Acts on arterial tree and venous bed, reducing total peripheral resistance and lowering venous return to heart.

Registrar Corp assists Phentolamine Mesylate companies with:

  • FDA Registration Phentolamine Mesylate
  • FDA Listing Phentolamine Mesylate
  • FDA Label Requirements and Exceptions Phentolamine Mesylate
  • FDA Import Information Phentolamine Mesylate
  • FDA Detentions Phentolamine Mesylate (Phentolamine Mesylate Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Phentolamine Mesylate (Phentolamine Mesylate Suppliers)
       - Processors Phentolamine Mesylate
       - Repackers Phentolamine Mesylate
       - Relabelers Phentolamine Mesylate
       - Exporters Phentolamine Mesylate
       - Importers Phentolamine Mesylate
For more information about Phentolamine Mesylate, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco